Skip to main content
Erschienen in:

30.04.2020 | Original Article - Vascular Neurosurgery - Other

Difference in periventricular anastomosis in child and adult moyamoya disease: a vascular morphology study

verfasst von: Jiwook Ryu, Eika Hamano, Masaki Nishimura, Tetsu Satow, Jun C. Takahashi

Erschienen in: Acta Neurochirurgica | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Backgrounds

Periventricular anastomosis (PA), which is a novel term for extended collateral vessels in moyamoya disease (MMD), is reportedly associated with a high risk of intracranial hemorrhage in adult patients. The present study aimed to clarify the similarities and the differences in the development of PA between three MMD groups, classified by age at the time of diagnosis and clinical phenotype.

Methods

This study included 232 hemispheres of 132 patients with MMD who underwent surgical revascularization. The subjects were classified into child ischemic (CI) group, adult ischemic (AI) group, and adult hemorrhagic (AH) group. We evaluated the lenticulostriate (LSA), thalamic (THA), choroidal (ChA), anterior choroidal (AChA), and posterior choroidal (PChA) anastomosis as well as the posterior cerebral artery (PCA) involvement. The PA scores and the sums of each grade of LSA, THA, and ChA anastomosis were also calculated in all of the cases.

Results

In a multiple comparison test, the PA scores (P < 0.01), LSA (P < 0.01), and ChA anastomosis (P = 0.013) were more prominent in the CI than in the AI group. The PA scores (P < 0.01) and LSA (P = 0.011), ChA (P < 0.01), AChA (P < 0.01), and PChA anastomosis (P = 0.016) were more prominent in the AH group than in the AI group. The CI and AH groups showed similar characteristics except for PCA involvement. After multivariate adjustments using the AI group as a reference group, the PA scores and the positive rates of LSA and ChA anastomosis remained significantly higher in the CI and AH groups.

Conclusion

The patterns of PA development in the CI and AH groups were similar in that they were more prominent than in the AI group. These findings may contribute to a better understanding of the progression of ischemic and hemorrhagic MMD.
Literatur
1.
Zurück zum Zitat Fujimura M, Funaki T, Houkin K, Takahashi JC, Kuroda S, Tomata Y, Tominaga T, Miyamoto S (2018) Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan Adult Moyamoya Trial. J Neurosurg:1–7. https://doi.org/10.3171/2017.11.jns171990 Fujimura M, Funaki T, Houkin K, Takahashi JC, Kuroda S, Tomata Y, Tominaga T, Miyamoto S (2018) Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan Adult Moyamoya Trial. J Neurosurg:1–7. https://​doi.​org/​10.​3171/​2017.​11.​jns171990
2.
Zurück zum Zitat Funaki T, Fushimi Y, Takahashi JC, Takagi Y, Araki Y, Yoshida K, Kikuchi T, Miyamoto S (2015) Visualization of periventricular collaterals in moyamoya disease with flow-sensitive black-blood magnetic resonance angiography: preliminary experience. Neurol Med Chir 55:204–209. https://doi.org/10.2176/nmc.oa.2014-0360 CrossRef Funaki T, Fushimi Y, Takahashi JC, Takagi Y, Araki Y, Yoshida K, Kikuchi T, Miyamoto S (2015) Visualization of periventricular collaterals in moyamoya disease with flow-sensitive black-blood magnetic resonance angiography: preliminary experience. Neurol Med Chir 55:204–209. https://​doi.​org/​10.​2176/​nmc.​oa.​2014-0360 CrossRef
5.
Zurück zum Zitat Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, Tomata Y, Miyamoto S (2018) High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg:1–8. https://doi.org/10.3171/2017.9.jns17576 Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, Tomata Y, Miyamoto S (2018) High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg:1–8. https://​doi.​org/​10.​3171/​2017.​9.​jns17576
7.
Zurück zum Zitat Hori S, Kashiwazaki D, Yamamoto S, Acker G, Czabanka M, Akioka N, Kuwayama N, Vajkoczy P, Kuroda S (2018) Impact of interethnic difference of collateral angioarchitectures on prevalence of hemorrhagic stroke in moyamoya disease. Neurosurgery. https://doi.org/10.1093/neuros/nyy236 Hori S, Kashiwazaki D, Yamamoto S, Acker G, Czabanka M, Akioka N, Kuwayama N, Vajkoczy P, Kuroda S (2018) Impact of interethnic difference of collateral angioarchitectures on prevalence of hemorrhagic stroke in moyamoya disease. Neurosurgery. https://​doi.​org/​10.​1093/​neuros/​nyy236
9.
Zurück zum Zitat Houkin K, Yoshimoto T, Kuroda S, Ishikawa T, Takahashi A, Abe H (1996) Angiographic analysis of moyamoya disease--how does moyamoya disease progress? Neurol Med Chir 36:783–787 discussion 788CrossRef Houkin K, Yoshimoto T, Kuroda S, Ishikawa T, Takahashi A, Abe H (1996) Angiographic analysis of moyamoya disease--how does moyamoya disease progress? Neurol Med Chir 36:783–787 discussion 788CrossRef
10.
Zurück zum Zitat Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S (2011) A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet 56:34–40. https://doi.org/10.1038/jhg.2010.132 CrossRefPubMed Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S (2011) A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet 56:34–40. https://​doi.​org/​10.​1038/​jhg.​2010.​132 CrossRefPubMed
12.
Zurück zum Zitat Kodama N (1971) [Possible function of the perforating arterial branches at the base of the brain in collateral circulation and their anatomical changes according to age-relationship to cerebrovascular “Moyamoya” disease]. No to shinkei =. Brain Nerve 23:1389–1402PubMed Kodama N (1971) [Possible function of the perforating arterial branches at the base of the brain in collateral circulation and their anatomical changes according to age-relationship to cerebrovascular “Moyamoya” disease]. No to shinkei =. Brain Nerve 23:1389–1402PubMed
14.
Zurück zum Zitat Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N (2012) Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78:803–810. https://doi.org/10.1212/WNL.0b013e318249f71f CrossRefPubMed Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N (2012) Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78:803–810. https://​doi.​org/​10.​1212/​WNL.​0b013e318249f71f​ CrossRefPubMed
16.
17.
Zurück zum Zitat Saeki N, Nakazaki S, Kubota M, Yamaura A, Hoshi S, Sunada S, Sunami K (1997) Hemorrhagic type moyamoya disease. Clin Neurol Neurosurg 99(Suppl 2):S196–S201CrossRef Saeki N, Nakazaki S, Kubota M, Yamaura A, Hoshi S, Sunada S, Sunami K (1997) Hemorrhagic type moyamoya disease. Clin Neurol Neurosurg 99(Suppl 2):S196–S201CrossRef
18.
Zurück zum Zitat Suzuki J, Kodama N (1983) Moyamoya disease--a review. Stroke 14:104–109CrossRef Suzuki J, Kodama N (1983) Moyamoya disease--a review. Stroke 14:104–109CrossRef
19.
Zurück zum Zitat Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Archives of neurology 20:288–299CrossRef Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Archives of neurology 20:288–299CrossRef
20.
Zurück zum Zitat Takahashi JC, Miyamoto S (2010) Moyamoya disease: recent progress and outlook. Neurol Med Chir 50:824–832CrossRef Takahashi JC, Miyamoto S (2010) Moyamoya disease: recent progress and outlook. Neurol Med Chir 50:824–832CrossRef
23.
24.
Zurück zum Zitat Yamashita M, Oka K, Tanaka K (1983) Histopathology of the brain vascular network in moyamoya disease. Stroke 14:50–58CrossRef Yamashita M, Oka K, Tanaka K (1983) Histopathology of the brain vascular network in moyamoya disease. Stroke 14:50–58CrossRef
Metadaten
Titel
Difference in periventricular anastomosis in child and adult moyamoya disease: a vascular morphology study
verfasst von
Jiwook Ryu
Eika Hamano
Masaki Nishimura
Tetsu Satow
Jun C. Takahashi
Publikationsdatum
30.04.2020
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 6/2020
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-020-04354-1

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

Schadet Schichtarbeit dem Gehirn?

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

Eine auf das B-Zell-Reifungsantigen gerichtete mRNA-basierte CAR-T-Zell-Therapie wurde jetzt in einer ersten Phase IIb-Studie zur Behandlung der generalisierten Myasthenia gravis mit Placebo verglichen.

Therapiestopp bei älteren MS-Kranken kann sich lohnen

Eine Analyse aus Kanada bestätigt: Setzen ältere MS-Kranke die Behandlung mit Basistherapeutika ab, müssen sie kaum mit neuen Schüben und MRT-Auffälligkeiten rechnen.

Obstruktive Schlafapnoe: Das steht abseits von CPAP auf dem Plan

Die obstruktive Schlafapnoe kann durch verschiedene Verfahren behandelt werden wie Lagetherapie und chirurgische Interventionen. Eine medikamentöse Therapie kommt zwar (noch) nicht infrage. Auf dem Pneumologie-Kongress wurden aber erste vielversprechende Ansätze präsentiert. 

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.